GALMED PHARMACEUTICALS LTD. Marketable Securities
GALMED PHARMACEUTICALS LTD. (GLMD) had Marketable Securities of $40.13 million as of 2020-12-31, per its 20-F filed 2021-03-18.
Discontinued › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2021-03-18
- 2020-12-31: Marketable Securities $40.13M.
- 2020-06-30: Marketable Securities $30.47M.
- 2019-12-31: Marketable Securities $31.62M.
- 2019-06-30: Marketable Securities $42.56M.
| Period end | Marketable Securities |
|---|---|
| 2020-12-31 | $40.13M 20-F · filed 2021-03-18 |
| 2020-06-30 | $30.47M 6-K · filed 2020-08-06 |
| 2019-12-31 | $31.62M 20-F · filed 2021-03-18 |
| 2019-06-30 | $42.56M 6-K · filed 2019-08-05 |
| 2018-12-31 | $59.96M 20-F · filed 2020-03-12 |
| 2018-06-30 | $87.95M 6-K · filed 2018-08-02 |
| 2017-12-31 | $5.98M 20-F · filed 2019-03-13 |
| 2017-06-30 | $7.41M 6-K · filed 2017-07-31 |
| 2016-12-31 | $12.35M 20-F · filed 2018-03-13 |
| 2016-06-30 | $13.74M 6-K · filed 2017-06-23 |
| 2015-12-31 | $18.84M 6-K · filed 2017-06-23 |
| 2014-12-31 | $2.25M 20-F · filed 2016-03-22 |
| 2013-12-31 | $0.00 20-F · filed 2015-03-31 |